A case of immunohistochemical false positive staining caused by incompatibility between a CD4 antibody and an autostainer.

Precise immunophenotyping of tumor cells by immunohistochemistry is complementary to morphological examination. It is critical for the correct histopathological diagnosis of lymphomas. In this paper, we report a case of T-cell lymphoma whose histopathological diagnosis was confounded by an immunohistochemical pitfall: a false positive caused by incompatibility between an antibody and an autostainer. In this case, based on CD4 immunohistochemistry of the affected lymph nodes, the T-cell lymphoma was diagnosed as CD4-positive at the onset, while it appeared discordantly to be CD4-negative at the second relapse. We noticed that CD4 antibodies and autostainers of different suppliers (designated as suppliers X and Y) were used in an unqualified combination in immunohistochemistry at the onset: that is, the combination of an antibody supplied by X and an autostainer supplied by Y (designated as X-Y combination) was used at the onset. On the other hand, the Y-Y combination was at the second relapse. At the second relapse, flow cytometry of the affected lymph node showed infiltration of CD4-negative T-cell lymphoma. We reasoned that CD4 immunonegativity obtained by the Y-Y combination at the second relapse was specific, while CD4 immunopositivity by the X-Y combination at the onset was false positive. Immunohistochemical reexamination of the lymph node at the onset proved to be CD4-negative by not only the Y-Y but also X-X combinations, confirming our final diagnosis of nodal relapse of CD4-negative T-cell lymphoma. This case illustrates the importance of using compatible combinations of antibodies and autostainers in diagnostic immunohistochemistry.

[1]  H. Vinters,et al.  Primary central nervous system histiocytic sarcoma presenting as a postradiation sarcoma: case report and literature review. , 2013, Human pathology.

[2]  Shigeo Nakamura,et al.  Down-regulation of CD 20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies : its prevalence and clinical significance , 2009 .

[3]  C. Schuerch,et al.  Histiocytic sarcoma in the small intestine: a case report with flow cytometry study and review of the literature. , 2008, Pathology, research and practice.

[4]  S. Billings,et al.  Myeloid leukemia cutis: a histologic and immunohistochemical review , 2007, Journal of cutaneous pathology.

[5]  D. Boue,et al.  Isolated Juvenile Xanthogranuloma in the Bone Marrow: Report of a Case and Review of the Literature , 2007, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[6]  G. Pruneri,et al.  SP4, a Novel Anti-Cyclin D1 Rabbit Monoclonal Antibody, Is a Highly Sensitive Probe for Identifying Mantle Cell Lymphomas Bearing the t(11;14)(q13;q32) Translocation , 2005, Applied immunohistochemistry & molecular morphology : AIMM.

[7]  A. D. Dei Tos,et al.  Rabbit monoclonal antibodies: a comparative study between a novel category of immunoreagents and the corresponding mouse monoclonal antibodies. , 2005, American journal of clinical pathology.

[8]  N. Akyürek,et al.  Interdigitating dendritic cell tumor with breast and cervical lymph-node involvement: a case report and review of the literature , 2005, Virchows Archiv.

[9]  J. Chan,et al.  Consistent Immunostaining for Cyclin D1 Can Be Achieved on a Routine Basis Using a Newly Available Rabbit Monoclonal Antibody , 2004, The American journal of surgical pathology.

[10]  R. Lyness,et al.  Histiocytic lymphoma presenting as a testicular tumour and terminating in acute monoblastic leukaemia , 2000, Journal of clinical pathology.